FINASTERIDE 0.25% + MINOXIDIL 5%
FINASTERIDE 0.25% / MINOXIDIL 5%
Dual-compound, solvent-based topical research formulation developed for localized, non-clinical 5α-reductase pathway and follicular response research studies.
Prefer email communication?
Request this formulation via our consultation form.
Request-only supply. No instant checkout. All formulation requests are reviewed before fulfilment.
Technical Data
Chemical Identification
Minoxidil
Dual-compound topical research formulation
Physicochemical Characteristics
Documentation & Analytical Data
Research Documentation
Formulation Specification
Concentration system: 0.25% w/v Finasteride + 5% w/v Minoxidil
Equivalent concentration: 2.5 mg/mL Finasteride + 50 mg/mL Minoxidil
Total active content: 125 mg Finasteride + 2.5 g Minoxidil per 50 mL
Vehicle system: Ethanol 96% (Ph. Eur.) / Propylene Glycol (Ph. Eur.) / Diethylene Glycol Monoethyl Ether — Transcutol® P (Ph. Eur.) / Purified Water (Ph. Eur.)
Solvent ratio: 45 / 27.5 / 12.5 / 15
Formulation architecture: Hydroalcoholic multi-solvent topical carrier system designed to support compound solubility, formulation consistency, and controlled surface application modeling.
Water content: Purified water included as part of the carrier system.
Formulation complexity: Dual-compound system
Research Context
This dual-compound topical formulation combines Finasteride and Minoxidil for non-clinical research models involving localized androgen pathway interaction, follicular response investigation, carrier-system compatibility, and surface-applied compound behavior.
In topical research contexts, the formulation is evaluated as a solvent-based dual-compound system where localized delivery behavior, compound dispersion, hydroalcoholic carrier compatibility, and formulation consistency are relevant experimental parameters.
Experimental focus is generally directed toward surface-confined delivery architecture, combined compound dispersion behavior, and controlled localized exposure modeling within non-clinical laboratory environments.
This GeneTherica formulation is positioned as a research-grade topical solution for controlled, non-clinical laboratory use. It is not supplied for therapeutic, diagnostic, cosmetic, or human application.
Storage & Handling
Storage range: 15–25°C under controlled room-temperature conditions.
Storage conditions: Store tightly closed in a cool, dry, dark environment.
Light sensitivity: Protect from direct sunlight and UV exposure.
Temperature stability: Avoid freezing and excessive heat exposure.
Air exposure: Minimize prolonged exposure to air.
Closure requirement: Keep container tightly sealed when not in use.
Stability context: Storage conditions are intended to support solvent balance, formulation consistency, and compound stability during controlled non-clinical handling.
Research Use Notice
Supplied exclusively for laboratory research and analytical applications.
Not intended for therapeutic, cosmetic, veterinary, food, household, diagnostic, or human application.
Handling should occur within qualified non-clinical research environments only.
Overview
Finasteride + Minoxidil is a multi-compound topical research formulation investigated within controlled non-clinical environments involving localized androgen pathway modulation and surface-level delivery system behavior.
Within topical research frameworks, Finasteride is commonly examined for its interaction with localized 5α-reductase-related signaling pathways, while Minoxidil is evaluated in experimental models involving localized tissue-response dynamics and surface-confined formulation exposure.
Experimental focus is generally directed toward localized biochemical interaction behavior, compound compatibility within hydroalcoholic carrier systems, and controlled delivery architecture associated with topical research formulations.
Research applications emphasize surface-confined topical carrier systems designed to support formulation consistency, compound dispersion behavior, and localized exposure modeling within controlled laboratory environments.
This formulation is presented as a research-grade topical solution intended exclusively for scientific, analytical, and laboratory-based investigation under appropriately controlled non-clinical handling conditions.
